Characterization of diabetic patients with Microalbuminuria
Keywords:
ALBUMINURIA, DIABETES MELLITUS, DIABETIC NEPHROPATHIES.Abstract
Background: diabetic nephropathy is the cause of 10 to 15 % of chronically ill terminal patients and a significant percentage are diagnosed in very advanced stages.
Objective: to characterize, from the clinical and epidemiological point of view, the diabetic patients with microalbuminuria from Las Tunas municipality and who were treated at the Diabetes Provincial Center during 2014.
Methods: a descriptive and cross-sectional study was carried out in 87 patients treated at the place and time mentioned above. Patients under 18 years old and those with more than 10 years of evolution of diabetes mellitus were excluded. Health histories were used as a secondary source of collecting information. The data were treated according to descriptive statistics and expressed in absolute and percentage values.
Results: the most frequent diabetes mellitus was type II in 86,2 % of patients; in 44,8 %, the time evolution of the disease was 1 to 3 years; the most frequent predisposing factor was hypertension in 62,1 %; in 41,4 % of the study sample, the 0,04 g / L semi-quantitative microalbuminuria predominated.
Conclusions: diabetic patients with microalbuminuria from Las Tunas municipality were characterized. More than half the sample had hypertension as a predisposing factor.
Downloads
References
Hernández Rodríguez A, Rodríguez Constantín A, Rodríguez Beyris R. Enfermedad renal oculta en pacientes con diabetes mellitus. MEDISAN [revista en internet]. 2011, Mar [citado 1 de abril 2016]; 15(3): 293-299. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011000300004&lng=es.
Marchetto R, Zamer J, Agostini M. Prevalencia de nefropatía en pacientes diabéticos tipo 2. Revista Médica De Rosario [revista en internet]. 2012, Oct [citada 1 de abril 2016]; 78(3): 118-124. Disponible en: MedicLatina.
Lou Arnal LM, Campos Gutiérrez B, Cuberes Izquierdo M, Gracia García O, Turón Alcaine JM, Bielsa García S, et al. Prevalencia de enfermedad renal crónica en pacientes con diabetes mellitus tipo 2 atendidos en atención primaria. Nefrología [revista en internet]. 2010 [citado 1 de abril 2016]; 30(5): 552-556. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952010000500011&lng=es.
Macisaac R, Ekinci E, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'. Kidney International [revista en internet]. 2014, Jul [citado 1 de abril 2016]; 86(1): 50-57. Disponible en: Academic Search Premier.
Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario estadístico de salud. MINSAP; 2014. Disponible en: http://files.sld.cu/bvscuba/files/2015/04/anuario-estadistico-de-salud-2014.pdf.
Bayram S, Gürsoy G, Araz Güngör A, Güngör F, Atalay E. The relationship of mean platelet volume with microalbuminuria in type 2 diabetic patients. Turkish Journal Of Medical Sciences [revista en internet]. 2016, Mar [citado 1 de abril 2016]; 46(2): 251-258. Disponible en: Academic Search Premier.
Moriya T, Tanaka S, Kawasaki R, Ohashi Y, Akanuma Y, Katayama S, et al. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study. Diabetes Care [revista en internet]. 2013, Sep [citado 1 de abril 2016]; 36(9): 2803-2809. Disponible en: MEDLINE Complete.
Ramos W, López T, Revilla L, More L, Huamaní M, Pozo M. Resultados de la vigilancia epidemiológica de diabetes mellitus en hospitales notificantes del perú, 2012. Revista Peruana De Medicina Experimental Y Salud Pública [revista en internet]. 2014, Enero [citado 1 de abril 2016]; 31(1): 9-15. Disponible en: MedicLatina.
Verzola D, Cappuccino L, D'Amato E, Villaggio B, Gianiorio F, Garibotto G, et al. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney International [revista en internet]. 2014, Dic [citado 1 de abril 2016]; 86(6): 1229-1243. Disponible en: MEDLINE Complete.
Liu F, Guo J, Zhang Q, Liu D, Wen L, Liu Z, et al. The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy. Plos ONE [revista en internet]. 2015, Oct [citado 1 abril 2016]; 10(10): 1-10. Disponible en: Academic Search Premier.
Overgaard A, McGuire J, Hovind P, Parving H, Rossing P, Pociot F. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients. Journal Of Diabetes And Its Complications [revista en internet]. 2013, enero [citado 1 de abril 2016]; 27(1): 59-63. Disponible en: MEDLINE Complete.
Chillarón J, Flores-Le-Roux J, Sales M, Jaume P, Castells I, Pedro-Botet J, et al. Prevalencia y factores asociados con la presencia de albuminuria y sus estadios en los pacientes con diabetes mellitus tipo 1. Nefrologia [revista en internet]. 2013, Mar [citado 1 de abril 2016]; 33(2): 231-236. Disponible en: MedicLatina.
Gul C, Oz Gul O, Cander S, Eroglu A, Hartavi M, İmamoğlu Ş, et al. Relationship between glycemic control, microalbuminuria and cognitive functions in elderly type 2 diabetic patients. Renal Failure [revista en internet]. 2014, Sep [citado 1 de abril 2016]; 36(8): 1258-1262. Disponible en: Academic Search Premier.
Sánchez Becerra D, Cuéllar Mata P, Delgadillo Mejía M, Durán Castro E, Deveze Álvarez M. Prevalencia de daño renal en pacientes diabéticos y/o hipertensos mediante prueba tamiz (RAC) en una clínica de Guanajuato. Revista Latinoamericana De Patología Clínica Y Medicina De Laboratorio [revista en internet]. 2012, Enero [citado 1 de abril 2016]; 59(1): 28-34. Disponible en: MedicLatina.
Barbieri M, Rizzo M, Fava I, Sardu C, Angelico N, Marfella R, et al. Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients. Disease Markers [revista en internet]. 2015, Dic [citado 1 de abril 2016]; 2015: 1-6. Disponible en: Academic Search Premier.
Morikawa A, Ishizeki K, Iwashima Y, Yokoyama H, Muto E, Haneda M, et al. Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study. Clinical And Experimental Nephrology [revista en internet]. 2011, Dic [citado 1 de abril 2016]; 15(6): 848-853. Disponible en: MEDLINE Complete.
Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. Journal Of Diabetes And Its Complications [revista en internet]. 2014, Mar [citado 1 de abril 2016]; 28(2): 124-129. Disponible en: MEDLINE Complete.
Molitch M, DeFronzo R, Franz M, Keane W, Mogensen C, Parving H. Diabetic nephropathy. Diabetes Care [revista en internet]. 2003, Enero [citado 4 de abril 2016]; 26(Suppl1): S94-S98. Disponible en: MEDLINE Complete.
Chavan V, Ramavataram D, Miyani K, Lad H, Nilakhe S. Prevalence of microalbuminuria as a marker of incipient nephropathy in type 2 diabetes patients at smimer hospital, surat. National Journal Of Community Medicine [revista en internet]. 2014, Oct [citado 1 de abril 2016]; 5(4): 468-473. Disponible en: Academic Search Premier.
López Gómez JM, Sacristán Enciso B, Micó M, Arias Meneses F, Sande Medel FD, Alejo S. Cistatina C sérica y microalbuminuria en la detección del daño vascular y renal en estadios precoces, en pacientes de riesgo sin enfermedad renal crónica. Nefrologia [revista en internet]. 2011, Oct [citado 1 de abril 2016]; 31(5): 560-565. Disponible en: MedicLatina.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.